These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9412295)

  • 21. Epoprostenol use in a National Pulmonary Hypertension Centre from 1997 to 2007.
    Church AC; Sanabria D; Peacock A; Johnson M
    Thorax; 2009 Jul; 64(7):642. PubMed ID: 19561289
    [No Abstract]   [Full Text] [Related]  

  • 22. Paradoxical effect of prostacyclin infusion in a patient with primary pulmonary hypertension-a case report.
    Younger JR; Lui CY
    Angiology; 2004; 55(3):341-4. PubMed ID: 15156270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epoprostenol for pulmonary hypertension in scleroderma.
    Klings ES; Farber HW
    Ann Intern Med; 2000 Jul; 133(2):158. PubMed ID: 10896643
    [No Abstract]   [Full Text] [Related]  

  • 24. Continuous intravenous prostacyclin for advanced primary pulmonary hypertension.
    Archer-Chicko C
    Dimens Crit Care Nurs; 2000; 19(2):14-21. PubMed ID: 10876492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report.
    Badalian SS; Silverman RK; Aubry RH; Longo J
    J Reprod Med; 2000 Feb; 45(2):149-52. PubMed ID: 10710749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epoprostenol and nesiritide in pulmonary hypertension.
    Rubin LJ
    Chest; 2005 May; 127(5):1870. PubMed ID: 15888882
    [No Abstract]   [Full Text] [Related]  

  • 27. Prostacyclin-analog therapy in sickle cell pulmonary hypertension.
    Weir NA; Saiyed R; Alam S; Conrey A; Desai HD; George MP; Keeley JH; Klings ES; Mehari A; Taylor JG; Minniti CP; Kato GJ
    Haematologica; 2017 May; 102(5):e163-e165. PubMed ID: 28126964
    [No Abstract]   [Full Text] [Related]  

  • 28. HIV-related pulmonary arterial hypertension: clinical presentation and management.
    Sitbon O
    AIDS; 2008 Sep; 22 Suppl 3():S55-62. PubMed ID: 18845923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension.
    Vanderpool RR; Desai AA; Knapp SM; Simon MA; Abidov A; Yuan JX; Garcia JGN; Hansen LM; Knoper SR; Naeije R; Rischard FP
    Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28838981
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful epoprostenol withdrawal in pulmonary arterial hypertension: case report and literature review.
    Demerouti EA; Manginas AN; Athanassopoulos GD; Karatasakis GT; Leontiadis ED; Pavlides GS
    Respir Care; 2013 Feb; 58(2):e1-5. PubMed ID: 22710078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-associated pulmonary hypertension.
    Farber HW
    AIDS Clin Care; 2001 Jun; 13(6):53-5, 59. PubMed ID: 11710309
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
    Reddy MT; Patel H; Ventura HO
    Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
    [No Abstract]   [Full Text] [Related]  

  • 33. [Primary pulmonary hypertension: treatment with prostacyclin before lung transplantation].
    Morales P; Almenar L; Cordero PJ; Vicente R; Ramos F; Borro JM
    Arch Bronconeumol; 1997 Mar; 33(3):148-50. PubMed ID: 9181989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostacyclin for pulmonary hypertension.
    Paramothayan NS; Lasserson TJ; Wells AU; Walters EH
    Cochrane Database Syst Rev; 2002; (3):CD002994. PubMed ID: 12137667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic evaluation of continuous intravenous epoprostenol.
    Chaumais MC; Jobard M; Huertas A; Vignand-Courtin C; Humbert M; Sitbon O; Rieutord A; Montani D
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1587-98. PubMed ID: 21077785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treprostinil for pulmonary hypertension.
    Skoro-Sajer N; Lang I; Naeije R
    Vasc Health Risk Manag; 2008; 4(3):507-13. PubMed ID: 18827901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of primary pulmonary hypertension.
    Handa S
    Intern Med; 2002 Oct; 41(10):757-8. PubMed ID: 12412989
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of pulmonary artery hypertension].
    Olschewski H; Seeger W
    Pneumologie; 2000 Jun; 54(6):222-4. PubMed ID: 10934891
    [No Abstract]   [Full Text] [Related]  

  • 39. Pulmonary hypertension--beyond vasodilator therapy.
    Fishman AP
    N Engl J Med; 1998 Jan; 338(5):321-2. PubMed ID: 9445414
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV-associated pulmonary hypertension: diagnosis and treatment.
    Burkart KM; Farber HW
    Adv Cardiol; 2003; 40():197-207. PubMed ID: 14533555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.